4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000056
EVP, Chief Scientific Officer sold 6,752 shares at $32.90 ($222,114)
- EVP, Chief Scientific Officer acquired 18,011 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BENNETT C FRANK · EVP, Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-15 | Exercise or conversion : show line 1 in the form | +18,011 | 97,618 | D | ||
| 2025-01-16 | Sale : show line 2 in the form | −6,752 | $32.90 | $222,114 | 90,866 | D |
| Open-market sales · 6,752 sh · avg $32.90 · $222,114 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-15 | Grant or award : show line 3 in the form Performance Restricted Stock Units | +22,000 | $0.00 | 22,000 | 63,482 | D |
| 2025-01-15 | Grant or award : show line 4 in the form Restricted Stock Unit | +33,000 | $0.00 | 33,000 | 56,500 | D |
| 2025-01-15 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −18,011 | $0.00 | 18,011 | 38,489 | D |
Loading xslF345X05/edgardoc.xml…